600216.SH
浙江医药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.55
−5.14%Margins
Gross margin
32.5%
EBITDA margin
20.0%
EBIT margin
9.2%
Net margin
8.5%
FCF margin
13.7%
6.7%
Return on equity
5.3%
Return on assets
6.8%
Return on invested capital
0.62x
Asset turnover
CNY 1.7B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026